NCT02344680View on ClinicalTrials.gov

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

Active, not recruitingOBSERVATIONAL
Enrollment

303

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Human Immunodeficiency VirusHBVFibrosis, LiverCirrhosis, LiverHepatocellular CarcinomaHepatitis Delta VirusAlcoholic Hepatitis
Interventions
DRUG

Anti-HIV Agents

Trial Locations (1)

34681

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka

All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT02344680 - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients | Biotech Hunter | Biotech Hunter